Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Geroscience. 2024 Oct;46(5):5171-5189. doi: 10.1007/s11357-024-01113-3. Epub 2024 Mar 15.
Time always leaves its mark, and our genome is no exception. Mutations in the genome of somatic cells were first hypothesized to be the cause of aging in the 1950s, shortly after the molecular structure of DNA had been described. Somatic mutation theories of aging are based on the fact that mutations in DNA as the ultimate template for all cellular functions are irreversible. However, it took until the 1990s to develop the methods to test if DNA mutations accumulate with age in different organs and tissues and estimate the severity of the problem. By now, numerous studies have documented the accumulation of somatic mutations with age in normal cells and tissues of mice, humans, and other animals, showing clock-like mutational signatures that provide information on the underlying causes of the mutations. In this review, we will first briefly discuss the recent advances in next-generation sequencing that now allow quantitative analysis of somatic mutations. Second, we will provide evidence that the mutation rate differs between cell types, with a focus on differences between germline and somatic mutation rate. Third, we will discuss somatic mutational signatures as measures of aging, environmental exposure, and activities of DNA repair processes. Fourth, we will explain the concept of clonally amplified somatic mutations, with a focus on clonal hematopoiesis. Fifth, we will briefly discuss somatic mutations in the transcriptome and in our other genome, i.e., the genome of mitochondria. We will end with a brief discussion of a possible causal contribution of somatic mutations to the aging process.
时间总会留下痕迹,我们的基因组也不例外。20 世纪 50 年代,在 DNA 的分子结构被描述之后不久,人们首次假设体细胞基因组中的突变是衰老的原因。体细胞衰老理论基于这样一个事实,即作为所有细胞功能的最终模板的 DNA 突变是不可逆转的。然而,直到 20 世纪 90 年代,才开发出方法来测试不同器官和组织中的 DNA 突变是否随年龄积累,并估计问题的严重程度。到目前为止,许多研究已经记录了在正常细胞和组织中,随着年龄的增长,体细胞突变的积累,这些组织包括小鼠、人类和其他动物,这些研究展示了具有时钟样突变特征的体细胞突变,这些特征提供了有关突变潜在原因的信息。在这篇综述中,我们将首先简要讨论最近在下一代测序方面的进展,这些进展现在允许对体细胞突变进行定量分析。其次,我们将提供证据表明,突变率在细胞类型之间存在差异,重点关注生殖细胞和体细胞突变率之间的差异。第三,我们将讨论体细胞突变特征作为衰老、环境暴露和 DNA 修复过程活性的衡量标准。第四,我们将解释克隆扩增体细胞突变的概念,重点介绍克隆性造血。第五,我们将简要讨论转录组和我们其他基因组(即线粒体基因组)中的体细胞突变。最后,我们将简要讨论体细胞突变对衰老过程可能具有因果贡献。